Medications for attention deficit hyperactivity disorder: cardiovascular concerns.
Wooltorton
Eric
E
D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D002170:Canada; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D000697:Central Nervous System Stimulants / Q000009:adverse effects* / Q000627:therapeutic use; D016757:Death, Sudden, Cardiac; D006801:Humans; D011356:Product Labeling; D012307:Risk Factors
D000697:Central Nervous System Stimulants